文献速递临床微生物分子诊断

Unyvero平台检测支气管肺泡灌洗液的多中心评估

Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage Fluid.
PubMed 文献 · J Clin Microbiol · 2021-02-18

该研究在美国11个临床试验点用1,016份前瞻性收集和392份存档的支气管肺泡灌洗液标本评估Unyvero LRT BAL多重分子 panel。该panel约4.5小时检测19种细菌、10种耐药标志物和耶氏肺孢子菌,与培养的总体阳性符合率为93.4%、阴性符合率为98.3%,耶氏肺孢子菌阳性符合率为87.5%,耐药标志物阳性预测值80%至100%。

要点

  • Unyvero检测细菌与常规培养的总体阳性符合率93.4%、阴性符合率98.3%。
  • 耶氏肺孢子菌检测与标准检测的阳性符合率为87.5%。
  • 耐药标志物阳性预测值按微生物和标志物不同为80%至100%。

核心结论

  • Unyvero LRT BAL Application能准确检测常见细菌性肺炎病原体和耶氏肺孢子菌,其敏感性和快速性对选择合适抗生素和抗菌药物管理有重要临床价值。

研究设计与样本

  • 多中心评估,使用美国11个临床试验点的1,016份前瞻性收集和392份存档支气管肺泡灌洗液标本。

主要发现

  • Unyvero检测常规培养可生长细菌的总体阳性符合率为93.4%,阴性符合率为98.3%。
  • 在21.7%的前瞻性收集标本中,Unyvero额外检出潜在病原体。
  • 耶氏肺孢子菌检测与标准检测的阳性符合率为87.5%。
  • 耐药标志物阳性预测值按微生物和特定耐药标志物为80%至100%。

关键数值与推荐

  • Unyvero LRT BAL Application约4.5小时检测19种细菌、10种抗生素耐药标志物和耶氏肺孢子菌。
  • 细菌鉴定与培养结果的总体阳性符合率93.4%、阴性符合率98.3%。
  • 耶氏肺孢子菌阳性符合率87.5%。
  • 耐药标志物阳性预测值范围80%至100%。

临床怎么用

  • 该panel的敏感性和快速性支持用于选择合适抗生素和抗菌药物管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bronchoalveolar lavage (BAL) culture is a standard, though time-consuming, approach for identifying microorganisms in patients with severe lower respiratory tract (LRT) infections. The sensitivity of BAL culture is relatively low, and prior antimicrobial therapy decreases the sensitivity further, leading to overuse of empirical antibiotics. The Unyvero LRT BAL Application (Curetis GmbH, Germany) is a multiplex molecular panel that detects 19 bacteria, 10 antibiotic resistance markers, and a fungus, Pneumocystis jirovecii, in BAL fluid in ∼4.5 h. Its performance was evaluated using 1,016 prospectively collected and 392 archived specimens from 11 clinical trial sites in the United States. Overall positive and negative percent agreements with culture results for identification of bacteria that grow in routine cultures were 93.4% and 98.3%, respectively, with additional potential pathogens identified by Unyvero in 21.7% of prospectively collected specimens. For detection of P. jirovecii, the positive percent agreement with standard testing was 87.5%. Antibiotic resistance marker results were compared to standard antibiotic susceptibility test results to determine positive predictive values (PPVs). PPVs ranged from 80 to 100%, based on the microorganism and specific resistance marker(s). The Unyvero LRT BAL Application provides accurate detection of common agents of bacterial pneumonia and of P. jirovecii The sensitivity and rapidity of this panel suggest significant clinical value for choosing appropriate antibiotics and for antibiotic stewardship.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Klein M, Bacher J, Barth S, et al. Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage Fluid. J Clin Microbiol. 2021. PMID: 33328178. doi:10.1128/JCM.02497-20

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。